whole exome sequencing wes (Integragen sa)
90
Structured Review
Integragen sa
whole exome sequencing wes
Whole Exome Sequencing Wes, supplied by Integragen sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raw+sequencing+data+processing+and+analysis/wes+library+preparation++exome+capture++sequencing+and+data+analysis/pmc05159768-77-0-10
Average 90 stars, based on 1 article reviews
Whole Exome Sequencing Wes, supplied by Integragen sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raw+sequencing+data+processing+and+analysis/wes+library+preparation++exome+capture++sequencing+and+data+analysis/pmc05159768-77-0-10
Average 90 stars, based on 1 article reviews
whole exome sequencing wes - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: 17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression. Article Snippet: K Le Guennec, O Quenez, G Nicolas, D Wallon, S Rousseau, A-C Richard, J Alexander, P Paschou, C Charbonnier, C Bellenguez, B Grenier-Boley, D Lechner, M-T Bihoreau, R Olaso, A Boland, V Meyer, J-F Deleuze, P Amouyel, HM Munter, G Bourque, M Lathrop, T Frebourg, R Redon, L Letenneur, J-F Dartigues, O Martinaud, O Kalev, S Mehrabian, L Traykov, T Ströbel, I Le Ber, P Caroppo, S Epelbaum, T Jonveaux, F Pasquier, A Rollin-Sillaire, E Génin, L Guyant-Maréchal, GG Kovacs, J-C Lambert, D Hannequin, D Campion, A Rovelet-Lecrux and The CNR-MAJ collaborators Whole-Exome Sequencing:Article Title: Dominant variants in the splicing factor PUF60 cause a recognizable syndrome with intellectual disability, heart defects and short stature Article Snippet: .. Sequencing:Article Title: A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma. Article Snippet: Department of Oncology, European Georges Pompidou Hospital, Assistance publique-hôpitaux de Paris (APHP)-Centre, Université Paris Cité, Paris Cancer Institute CARPEM, Paris, France Department of Biochemistry, Molecular Oncology and Pharmacogenetics, European Georges Pompidou Hospital, APHP-Centre, Université Paris Cité, Paris Cancer Institute CARPEM, Paris, France Centre de Recherche des Cordeliers -Sorbonne UniversitéUniversité de Paris Cité, INSERM, Team Personalized Medicine, Pharmacogenomics and Therapeutic Optimization (MEPPOT), Paris, France INSERM UMR 970, Paris Cardiovascular Research Center (PARCC), Université Paris Cité, Paris, France Department of Genetic, European Georges Pompidou Hospital, APHP-Centre, Université Paris Cité, Paris, France Department of Pathology, Hôpital Cochin, APHP-Centre, Université Paris Cité, Paris Cancer Institute CARPEM, Paris, France Department of Urology, European Georges Pompidou Hospital, APHP-Centre, Université Paris Cité, Paris Cancer Institute CARPEM, Paris, France Department of Pathology, European Georges Pompidou Hospital, APHP-Centre, Université Paris Cité, Paris Cancer Institute CARPEM, Paris, France |
